"Even though this was my first experience in a clinical trial, I was never anxious about the treatment involving mainline chemotherapy in combination with a new monoclonal antibody for multiple myeloma. I had faith in Dr. Yimer, and I had faith because the drug had been successful in other trials. I truly felt it was the best option and was willing to try anything,” said Dwayne Collins."
READ NOW >